UCBJY
Price
$79.23
Change
-$0.29 (-0.36%)
Updated
Apr 8 closing price
Capitalization
30.07B
14 days until earnings call
VANI
Price
$1.02
Change
-$0.00 (-0.00%)
Updated
Apr 8 closing price
Capitalization
60.72M
40 days until earnings call
Ad is loading...

UCBJY vs VANI

Header iconUCBJY vs VANI Comparison
Open Charts UCBJY vs VANIBanner chart's image
UCB S.A
Price$79.23
Change-$0.29 (-0.36%)
Volume$93.48K
Capitalization30.07B
Vivani Medical
Price$1.02
Change-$0.00 (-0.00%)
Volume$132.93K
Capitalization60.72M
UCBJY vs VANI Comparison Chart
Loading...
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
UCBJY vs. VANI commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UCBJY is a Hold and VANI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (UCBJY: $79.53 vs. VANI: $1.02)
Brand notoriety: UCBJY and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: UCBJY: 192% vs. VANI: 163%
Market capitalization -- UCBJY: $30.07B vs. VANI: $60.72M
UCBJY [@Biotechnology] is valued at $30.07B. VANI’s [@Biotechnology] market capitalization is $60.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

UCBJY’s FA Score shows that 2 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • UCBJY’s FA Score: 2 green, 3 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, UCBJY is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UCBJY’s TA Score shows that 3 TA indicator(s) are bullish while VANI’s TA Score has 4 bullish TA indicator(s).

  • UCBJY’s TA Score: 3 bullish, 7 bearish.
  • VANI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VANI is a better buy in the short-term than UCBJY.

Price Growth

UCBJY (@Biotechnology) experienced а -9.92% price change this week, while VANI (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.88%. For the same industry, the average monthly price growth was -20.27%, and the average quarterly price growth was -19.68%.

Reported Earning Dates

UCBJY is expected to report earnings on Jul 24, 2025.

VANI is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (-9.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UCBJY($30.1B) has a higher market cap than VANI($60.7M). VANI YTD gains are higher at: -12.069 vs. UCBJY (-19.843). UCBJY has higher annual earnings (EBITDA): 1.96B vs. VANI (-24.03M). UCBJY has more cash in the bank: 1.76B vs. VANI (19.6M). VANI has less debt than UCBJY: VANI (19.7M) vs UCBJY (3.03B). UCBJY has higher revenues than VANI: UCBJY (6.15B) vs VANI (0).
UCBJYVANIUCBJY / VANI
Capitalization30.1B60.7M49,588%
EBITDA1.96B-24.03M-8,171%
Gain YTD-19.843-12.069164%
P/E Ratio26.33N/A-
Revenue6.15B0-
Total Cash1.76B19.6M8,964%
Total Debt3.03B19.7M15,360%
FUNDAMENTALS RATINGS
UCBJY vs VANI: Fundamental Ratings
UCBJY
VANI
OUTLOOK RATING
1..100
5783
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
33100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6183
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UCBJY's Valuation (2) in the null industry is somewhat better than the same rating for VANI (47). This means that UCBJY’s stock grew somewhat faster than VANI’s over the last 12 months.

UCBJY's Profit vs Risk Rating (33) in the null industry is significantly better than the same rating for VANI (100). This means that UCBJY’s stock grew significantly faster than VANI’s over the last 12 months.

UCBJY's SMR Rating (96) in the null industry is in the same range as VANI (100). This means that UCBJY’s stock grew similarly to VANI’s over the last 12 months.

UCBJY's Price Growth Rating (61) in the null industry is in the same range as VANI (83). This means that UCBJY’s stock grew similarly to VANI’s over the last 12 months.

UCBJY's P/E Growth Rating (95) in the null industry is in the same range as VANI (100). This means that UCBJY’s stock grew similarly to VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
UCBJYVANI
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
64%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
40%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GUBGX14.26N/A
N/A
Victory RS International A
SXPCX41.15N/A
N/A
DWS S&P 500 Index C
MSHMX12.05N/A
N/A
Morgan Stanley Inst Permanence I
ASQAX13.07N/A
N/A
American Century Small Company A
PWJBX26.51N/A
N/A
PGIM Jennison International Opps R2

UCBJY and

Correlation & Price change

A.I.dvisor tells us that UCBJY and GBIO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJY and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJY
1D Price
Change %
UCBJY100%
-0.37%
GBIO - UCBJY
28%
Poorly correlated
-13.69%
VANI - UCBJY
26%
Poorly correlated
N/A
ABOS - UCBJY
24%
Poorly correlated
-7.22%
TNYA - UCBJY
23%
Poorly correlated
-13.18%
ARWR - UCBJY
23%
Poorly correlated
-2.54%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
N/A
VTVT - VANI
60%
Loosely correlated
+2.93%
ADIL - VANI
37%
Loosely correlated
+5.56%
AXSM - VANI
36%
Loosely correlated
-0.96%
RGNX - VANI
34%
Loosely correlated
-10.46%
SCNI - VANI
34%
Loosely correlated
-8.83%
More